J. Heidebrink

发表

FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease.

C. DeCarli, W. Jagust, R. Koeppe, 2007, Brain : a journal of neurology.

A comparison of classification methods for differentiating fronto‐temporal dementia from Alzheimer's disease using FDG‐PET imaging

Raymond Scott Turner, C. DeCarli, W. Jagust, 2004, Statistics in medicine.

Predicting Alzheimer’s disease progression using multi-modal deep learning approach

Sterling C. Johnson, David T. Jones, Nick C Fox, 2019, Scientific Reports.

Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease

Alan C. Evans, Sterling C. Johnson, Keith A. Johnson, 2019, bioRxiv.

Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss.

N. Foster, S. Berent, B. Giordani, 2001, Archives of neurology.

A semi-mechanism approach based on MRI and proteomics for prediction of conversion from mild cognitive impairment to Alzheimer’s disease

Sterling C. Johnson, David T. Jones, Nick C Fox, 2016, Scientific Reports.

Robust Identification of Alzheimer’s Disease subtypes based on cortical atrophy patterns

Norbert Schuff, Robert C. Green, Andrew J. Saykin, 2017 .

Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis

Norbert Schuff, Michael W. Weiner, Robert C. Green, 2016, Nature Communications.

Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer’s pathology

Sterling C. Johnson, David T. Jones, Taylor W. Schmitz, 2016, Nature Communications.

Author Correction: Multimodal hippocampal subfield grading for Alzheimer’s disease classification

Norbert Schuff, Michael W. Weiner, Robert C. Green, 2020, Scientific Reports.

Structural Brain Changes in Pre-Clinical FTD MAPT Mutation Carriers.

A. Brickman, H. Paulson, Seonjoo Lee, 2020, Journal of Alzheimer's disease : JAD.

The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory

Sterling C. Johnson, Keith A. Johnson, Joanne L. Lord, 2019, Nature Communications.

18F-florbetapir Positron Emission Tomography–determined Cerebral &bgr;-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery

David T. Jones, Keith A. Johnson, Jeffrey N. Browndyke, 2018, Anesthesiology.

FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease

Sterling C. Johnson, David T. Jones, Keith A. Johnson, 2020, Nature Communications.

A predictive model using the mesoscopic architecture of the living brain to detect Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2022, Communications Medicine.

Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2022, GeroScience.

An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2022, Nature Aging.

A Blood Test for Alzheimer's Disease: It's about Time or Not Ready for Prime Time?

D. Galasko, J. Heidebrink, J. Lingler, 2022, Journal of Alzheimer's disease : JAD.

Temporoparietal hypometabolism is common in FTLD and is associated with imaging diagnostic errors

Raymond Scott Turner, C. DeCarli, W. Jagust, 2011 .

The Advisory Group on Risk Evidence Education for Dementia: Multidisciplinary and Open to All

Suzanne E. Schindler, E. Wijsman, D. Blacker, 2022, Journal of Alzheimer's disease : JAD.

Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases

Sterling C. Johnson, Nick C Fox, Keith A. Johnson, 2012, Neurology.

Preclinical Alzheimer Disease and the Electronic Health Record: Balancing Confidentiality and Care.

Susie A. Sami, W. Menard, J. Karlawish, 2022, Neurology.

Genetic studies of plasma analytes identify novel potential biomarkers for several complex traits

Norbert Schuff, Michael W. Weiner, Robert C. Green, 2016, Scientific Reports.

P3-065 FDG-PET improves differential diagnosis of dementia when clinical history and examination are ambiguous

C. DeCarli, W. Jagust, R. Koeppe, 2004, Neurobiology of Aging.

P3-070 Adding FDG-PET to clinical history and examination improves the accuracy of dementia diagnosis

C. DeCarli, W. Jagust, R. Koeppe, 2004, Neurobiology of Aging.

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease

Nick C Fox, Keith A. Johnson, Raymond Scott Turner, 2022, Nature Communications.

Is treatment with aspirin combined with dipyridamole really more cost-effective than aspirin alone?

J. Heidebrink, 2001, Archives of internal medicine.

Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans

Norbert Schuff, Adrian Preda, John Kornak, 2012, Proceedings of the National Academy of Sciences.

Correlation between Alzheimer’s disease and type 2 diabetes using non-negative matrix factorization

Keith A. Johnson, Raymond Scott Turner, Joanne L. Lord, 2021, Scientific Reports.

Women can bear a bigger burden: ante- and post-mortem evidence for reserve in the face of tau

Sterling C. Johnson, Nick C Fox, John X. Morris, 2020, Brain communications.

The impact of PICALM genetic variations on reserve capacity of posterior cingulate in AD continuum

Sterling C. Johnson, Keith A. Johnson, Joanne L. Lord, 2016, Scientific Reports.

Effect of CR1 Genetic Variants on Cerebrospinal Fluid and Neuroimaging Biomarkers in Healthy, Mild Cognitive Impairment and Alzheimer's Disease Cohorts

Keith A. Johnson, Joanne L. Lord, Colleen S. Albers, 2016, Molecular Neurobiology.

Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial.

G. Schellenberg, P. Peduzzi, J. McCarten, 2014, JAMA.

Ferritin levels in the cerebrospinal fluid predict Alzheimer’s disease outcomes and are regulated by APOE

Keith A. Johnson, Scott Ayton, Joanne L. Lord, 2015, Nature Communications.

Genome-wide association analysis of hippocampal volume identifies enrichment of neurogenesis-related pathways

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2016, Scientific Reports.

Validation of consensus panel diagnosis in dementia.

W. Jagust, B. Boeve, S. DeKosky, 2010, Archives of neurology.

Accelerated functional brain aging in pre-clinical familial Alzheimer’s disease

Sterling C. Johnson, Christine L. Tardif, John X. Morris, 2021, Nature Communications.

The Polygenic Risk Score Knowledge Base offers a centralized online repository for calculating and contextualizing polygenic risk scores

Mark T. W. Ebbert, Raymond Scott Turner, Owen Carmichael, 2021, Communications Biology.

Non-coding variability at the APOE locus contributes to the Alzheimer’s risk

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2019, Nature Communications.

Four distinct trajectories of tau deposition identified in Alzheimer’s disease

Sterling C. Johnson, John X. Morris, Keith A. Johnson, 2021, Nature Medicine.

Mining Outcome-relevant Brain Imaging Genetic Associations via Three-way Sparse Canonical Correlation Analysis in Alzheimer’s Disease

Michael W. Weiner, Robert C. Green, Shannon L. Risacher, 2017, Scientific Reports.

Predicting Alzheimer’s disease progression using multi-modal deep learning approach

Keith A. Johnson, Sherye A. Sirrel, Alice D. Brown, 2019, Scientific Reports.

Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2022, Nature Communications.

Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer’s disease

Andrew J. Saykin, Arthur W. Toga, Qianjin Feng, 2017, Scientific Reports.

Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2016, Scientific Reports.

Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease

Keith A. Johnson, Charles D. Smith, Sherye A. Sirrel, 2020, Nature Communications.

Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study

Nick C Fox, Keith A. Johnson, Raymond Scott Turner, 2021, Translational Psychiatry.

KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2021, Nature Communications.

Vitamin E and memantine in Alzheimer's disease: Clinical trial methods and baseline data

G. Schellenberg, J. McCarten, M. Sano, 2014, Alzheimer's & Dementia.

A Novel Joint Brain Network Analysis Using Longitudinal Alzheimer’s Disease Data

Norbert Schuff, Michael W. Weiner, Andrew J. Saykin, 2019, Scientific Reports.

The trend of disruption in the functional brain network topology of Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2021, Scientific Reports.

Glucose metabolism patterns: A potential index to characterize brain ageing and predict high conversion risk into cognitive impairment

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2022, GeroScience.

Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer’s Dementia

Sterling C. Johnson, Keith A. Johnson, Charles D. Smith, 2018, Molecular Neurobiology.

Neurologic examination in the elderly.

H. Paulson, J. Heidebrink, Navid Seraji-Bzorgzad, 2019, Handbook of clinical neurology.

Psychiatric symptoms in preclinical behavioural-variant frontotemporal dementia in MAPT mutation carriers

H. Paulson, Seonjoo Lee, E. Huey, 2018, Journal of Neurology Neurosurgery & Psychiatry.

Caregiver Support Service Needs for Patients With Mild Cognitive Impairment and Alzheimer Disease

B. Giordani, J. Heidebrink, N. Barbas, 2010, Alzheimer disease and associated disorders.

Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference

Nick C Fox, Keith A. Johnson, Raymond Scott Turner, 2017, Nature Communications.

Deep learning-based polygenic risk analysis for Alzheimer’s disease prediction

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2023, Communications Medicine.

Reliability of Repeated Cognitive Assessment of Dementia Using a Brief Computerized Battery

R. Albin, K. Frey, D. Darby, 2011, American journal of Alzheimer's disease and other dementias.

Self- and Informant-Reported Memory Complaints: Frequency and Severity in Cognitively Intact Individuals and those with Mild Cognitive Impairment and Neurodegenerative Dementias.

B. Hampstead, B. Giordani, J. Heidebrink, 2018, Journal of Alzheimer's disease : JAD.

Validity of a Brief Computerized Cognitive Screening Test in Dementia

D. Darby, B. Giordani, J. Heidebrink, 2012, Journal of geriatric psychiatry and neurology.

Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics

Norbert Schuff, Michael W. Weiner, Robert C. Green, 2019, Scientific Reports.

Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status

Sterling C. Johnson, Nick C Fox, Keith A. Johnson, 2021, Translational Psychiatry.

Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors.

Raymond Scott Turner, C. DeCarli, W. Jagust, 2011, Archives of neurology.

Dissection of the polygenic architecture of neuronal Aβ production using a large sample of individual iPSC lines derived from Alzheimer’s disease patients

Keith A. Johnson, Raymond Scott Turner, Charles D. Smith, 2022, Nature Aging.

Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer’s Disease via Fusion of Clinical, Imaging and Omic Features

Adrian Preda, Evan Fletcher, Charles DeCarli, 2017, Scientific Reports.

Brain multiplexes reveal morphological connectional biomarkers fingerprinting late brain dementia states

Islem Rekik, Mohamed Ali Mahjoub, Keith A. Johnson, 2018, Scientific Reports.

The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2019, Nature Communications.

Cognitive Indicators of Preclinical Behavioral Variant Frontotemporal Dementia in MAPT Carriers

H. Paulson, Seonjoo Lee, E. Huey, 2018, Journal of the International Neuropsychological Society.

Diagnostic Profiles of Patients Differentially Failing Executive Functioning Measures

B. Giordani, J. Heidebrink, N. Barbas, 2016, American journal of Alzheimer's disease and other dementias.

Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics

Keith A. Johnson, Michael W. Paul Ronald Clifford R. Andrew J. William John Weiner Aisen Petersen Jack Saykin Jagust , Sherye A. Sirrel, 2019, Scientific Reports.

Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology

György J. Simon, David T. Jones, Keith A. Johnson, 2020, Scientific Reports.

Higher CSF sTNFR1-related proteins associate with better prognosis in very early Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2021, Nature Communications.

Is Dementia with Lewy Bodies the Second Most Common Cause of Dementia?

J. Heidebrink, 2002, Journal of geriatric psychiatry and neurology.

Neuropsychiatric Symptoms and Executive Functioning in Patients with Mild Cognitive Impairment: Relationship to Caregiver Burden

B. Giordani, J. Heidebrink, N. Barbas, 2012, Dementia and Geriatric Cognitive Disorders.

Laptop-Administered NIH Toolbox and Cogstate Brief Battery in Community-Dwelling Black Adults: Unexpected Pattern of Cognitive Performance between MCI and Healthy Controls

B. Giordani, A. Daugherty, J. Heidebrink, 2021, Journal of the International Neuropsychological Society.

Agreement among neuropsychological and behavioral data and PiB findings in diagnosing Frontotemporal Dementia

R. Albin, K. Frey, B. Giordani, 2017, Journal of Clinical Neuroscience.

A telescope GWAS analysis strategy, based on SNPs-genes-pathways ensamble and on multivariate algorithms, to characterize late onset Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Sherye A. Sirrel, 2020, Scientific Reports.

Evaluation of the Uniform Data Set version 3 teleneuropsychological measures

B. Hampstead, J. Heidebrink, A. Rahman-Filipiak, 2023, Journal of the International Neuropsychological Society.

A multicenter, randomized, placebo controlled, multiple-dose, safety and pharmacokinetic study of AIT-082 (Neotrofin) in mild Alzheimer's disease patients.

John X. Morris, L. Thal, J. Morris, 2003, Life sciences.

Living at Risk: The Sibling’s Perspective of Early-Onset Alzheimer’s Disease

J. Roberts, J. Heidebrink, W. Uhlmann, 2009, Journal of Genetic Counseling.

18F-florbetapir Positron Emission Tomography-determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery.

Sterling C. Johnson, David T. Jones, Keith A. Johnson, 2018, Anesthesiology.

Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease

Sterling C. Johnson, Keith A. Johnson, Charles D. Smith, 2020, Nature Communications.

Non-coding variability at the APOE locus contributes to the Alzheimerâ€TMs risk

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2019 .

Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology

Norbert Schuff, Michael W. Weiner, Andrew J. Saykin, 2020, Scientific Reports.

FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease

David T. Jones, Keith A. Johnson, Charles D. Smith, 2020, Nature Communications.

Genome-wide association analysis of hippocampal volume identifies enrichment of neurogenesis-related pathways

John X. Morris, Keith A. Johnson, Raymond Scott Turner, 2019, Scientific Reports.

GenEpi: gene-based epistasis discovery using machine learning

Michael W. Weiner, Yen-Jen Oyang, Arthur W. Toga, 2018, BMC Bioinformatics.

A blood-based signature of cerebrospinal fluid Aβ1–42 status

John X. Morris, Keith A. Johnson, Raymond Scott Turner, 2019, Scientific Reports.

Characteristic patterns of inter- and intra-hemispheric metabolic connectivity in patients with stable and progressive mild cognitive impairment and Alzheimer’s disease

Keith A. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2018, Scientific Reports.

Dissection of the polygenic architecture of neuronal Aβ production using a large sample of individual iPSC lines derived from Alzheimer’s disease patients

Sterling C. Johnson, Keith A. Johnson, Raymond Scott Turner, 2022, Nature Aging.

Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts

Sterling C. Johnson, Raymond Scott Turner, Sherye A. Sirrel, 2016, Scientific Reports.

Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors.

Raymond Scott Turner, C. DeCarli, W. Jagust, 2011, Archives of neurology.

Prognostic relevance of gait-related cognitive functions for dementia conversion in amnestic mild cognitive impairment

John X. Morris, Keith A. Johnson, Raymond Scott Turner, 2023, BMC Geriatrics.

A blood-based signature of cerebrospinal fluid Aβ1–42 status

Raymond Scott Turner, Sherye A. Sirrel, Alice D. Brown, 2019, Scientific Reports.

A comparison of classification methods for differentiating fronto‐temporal dementia from Alzheimer's disease using FDG‐PET imaging

Raymond Scott Turner, C. DeCarli, W. Jagust, 2004, Statistics in Medicine.

Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE

Sterling C. Johnson, Sherye A. Sirrel, Alice D. Brown, 2015, Nature Communications.

Dementia with Lewy Bodies: From Obscurity to Ubiquity

J. Heidebrink, 2002 .

Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration

Sterling C. Johnson, Raymond Scott Turner, Alice D. Brown, 2020, Molecular neurodegeneration.

Polygenic effects on the risk of Alzheimer’s disease in the Japanese population

Raymond Scott Turner, Sherye A. Sirrel, Alice D. Brown, 2024, Alzheimer's research & therapy.

Robust Identification of Alzheimer’s Disease subtypes based on cortical atrophy patterns

Sterling C. Johnson, David T. Jones, Nick C Fox, 2017, Scientific Reports.